Data as of Q4 2025 (Dec 31, 2025)

Alphabet Inc.

โ€ขCIK: 1652044โ€ขFiling: Q4 2025

**Alphabet Inc.** manages a $2.6B AUM across 29 diverse positions, signaling a concentrated, high-conviction approach. The portfolio is heavily weighted toward technology and growth plays, anchored by significant allocations to ASTS ($649.6M) and PL ($629.9M). Notable secondary holdings include RVMD ($266.4M) and ARM ($214.3M), indicating deep sector conviction across multiple high-growth verticals. This structure suggests an aggressive mandate focused on capturing outsized returns from market leaders and emerging tech sectors.

Total AUM
$2.6B
QoQ Performance
+7.1%
Positions
29
Top 10 Concentration
92.8%
Latest Filing
Q4 2025

Top Holdings Allocation

ASTS
PL
RVMD
ARM
FRSH
ASTS25.2%
PL24.4%
RVMD10.3%
ARM8.3%
FRSH7.7%
PATH4.5%
GTLB4.0%
TEM3.6%

๐Ÿ“ˆ Biggest Buys

No new positions or increases this quarter

๐Ÿ“‰ Biggest Sells

RVMD
REVOLUTION MEDICINES INC
-19.1%
10.3% of portfolio
MAZE
MAZE THERAPEUTICS INC
-42.4%
2.2% of portfolio
GLUE
MONTE ROSA THERAPEUTICS INC
-49.1%
0.5% of portfolio

Sector Breakdown

Other100.0%

๐Ÿšช Exited Positionssold since Q3 2025

โ€”
METSERA INC
SOLD
$198.0M
DNTH
DIANTHUS THERAPEUTICS INC
SOLD
$8.2M
FHTX
FOGHORN THERAPEUTICS INC
SOLD
$2.4M
TSHA
TAYSHA GENE THERAPIES INC
SOLD
$2.1M
TCRX
TSCAN THERAPEUTICS INC
SOLD
$2.0M
+3 more exited positions

Changes from Q3 2025

โ†“3 decreased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023